Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pulsed ACTH add-on to Avonex in RRMS
NCT00986960Phase 2Withdrawn
- Sponsor
- University at Buffalo
- Start
- Dec 2009
- Primary completion
- Sep 2010
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of repository corticotropin injection in relapsing-remitting multiple sclerosis (RRMS), sponsored by University at Buffalo. Planned start Dec 2009; status: withdrawn.
02
Drugs
repository corticotropin injection
03
Conditions
relapsing-remitting multiple sclerosis (RRMS)
Beyond the preview
Go deeper on NCT00986960.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00986960.